SCHEMBL23725191

SCHEMBL23725191

COc1c(C(=O)O)cc(Cl)c2nc(Cl)c(C)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.40
HSD17B10 Q99714 3/20 0.39
ALDH1A1 P00352 5/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 2/20 0.39
HTT P42858 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 2/20 0.39
TPMT P51580 1/20 0.38
KDM4E B2RXH2 5/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPK1 P28482 1/20 0.37
GPR35 Q9HC97 2/20 0.37
POLB P06746 1/20 0.37
SORT1 Q99523 1/20 0.36
ACLY P53396 2/20 0.36
PPARA Q07869 1/20 0.36
CTSL P07711 1/20 0.35
MAPT P10636 1/20 0.35
CRHBP P24387 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23725858 0.80 KDM4E (0.50) NOTUMHSD17B10ALDH1A1HPGDMEN1
SCHEMBL23725371 0.73 HIF1A (0.48) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL29657217 0.72 POLB (0.49) HSD17B10ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL27859515 0.71 TPMT (0.53) NOTUMHSD17B10ALDH1A1HPGDMEN1
SCHEMBL8967049 0.71 ALDH1A1 (0.60) NOTUMHSD17B10ALDH1A1HPGDMEN1
SCHEMBL27263838 0.70 HSD17B10 (0.49) NOTUMHSD17B10ALDH1A1HPGDMEN1
SCHEMBL7006578 0.70 HSD17B10 (0.49) NOTUMHSD17B10ALDH1A1HPGDMEN1
SCHEMBL27887946 0.69 TPMT (0.47) NOTUMHSD17B10ALDH1A1HPGDMEN1
SCHEMBL1330488 0.69 KEAP1 (0.60) NOTUMHSD17B10ALDH1A1HPGDLMNA
SCHEMBL4258802 0.69 PDE4A (0.43) NOTUMHSD17B10ALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL NOTUM 1006/4885HSD17B10 633/4885ALDH1A1 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.